{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:46:38Z","timestamp":1760906798579},"reference-count":41,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,3,21]],"date-time":"2003-03-21T00:00:00Z","timestamp":1048204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prenatal Diagnosis"],"published-print":{"date-parts":[[2003,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To describe a new approach to antenatal screening for Fragile X syndrome and to evaluate its effectiveness.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We propose that Fragile X syndrome should be considered as a different disorder in males and in females. We also propose that only male Fragile X syndrome should be screened for, so the initial screening test would be the determination of fetal sex. This can now be performed from eight\u2010weeks gestation using a polymerase chain reaction (PCR) analysis on maternal serum. If this test reveals a male fetus, then the same blood sample can be used to determine the CGG repeat length in the DNA of the mother, again using the PCR technique and a Southern blot analysis where necessary. Mothers with positive results (&gt;58 repeats) would be offered antenatal diagnosis (chorionic villus sampling or amniocentesis) to determine the CGG repeat length in cells from the fetus. The screening performance of this strategy was determined using the performance of the component tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The proposed strategy for screening for male Fragile X syndrome would have a 99% detection rate and a 0.1% false\u2010positive rate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>After antenatal screening for Down syndrome, the proposed screening strategy would be the most effective method of preventing the birth of males with severe mental retardation. It would have a higher detection rate and a lower false\u2010positive rate than any other antenatal screening programme currently being undertaken, and there would be virtually no prenatal diagnosis of female Fragile X syndrome, which, because such a high proportion are phenotypically normal, has been a barrier to the introduction of screening. Copyright \u00a9 2003 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pd.586","type":"journal-article","created":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T19:05:16Z","timestamp":1049223916000},"page":"345-351","source":"Crossref","is-referenced-by-count":9,"title":["A new approach to antenatal screening for Fragile X syndrome"],"prefix":"10.1002","volume":"23","author":[{"given":"N. J.","family":"Wald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. K.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,3,21]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320510407"},{"key":"e_1_2_1_3_1","first-page":"1414","article-title":"Population dynamics of a meiotic\/mitotic expansion model for the Fragile X syndrome","volume":"57","author":"Ashley AE","year":"1995","journal-title":"Am J Hum Genet"},{"key":"e_1_2_1_4_1","first-page":"210","volume-title":"Fragile X Syndrome. Diagnosis, Treatment and Research","author":"Bennetto LMA","year":"1996"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jama.1993.03510130075034","article-title":"Rapid Fragile X carrier screening and prenatal diagnosis by a non\u2010radioactive PCR test","volume":"270","author":"Brown WT","year":"1993","journal-title":"J Am Med Assoc"},{"key":"e_1_2_1_6_1","first-page":"88","volume-title":"Fragile X Syndrome. Diagnosis, Treatment and Research","author":"Brown WT","year":"1996"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19960712)64:1<191::AID-AJMG34>3.0.CO;2-G"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/pd.219"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320380272"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7018.1460"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1006\/bmme.1995.1057"},{"key":"e_1_2_1_12_1","first-page":"1025","article-title":"Mental status of females with an FMR1 gene full mutation","volume":"58","author":"de Vries BBA","year":"1996","journal-title":"Am J Hum Genet"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6266.789"},{"key":"e_1_2_1_14_1","first-page":"1147","article-title":"The Fragile X pre\u2010mutation in carriers and its effect on mutation size in offspring","volume":"56","author":"Fisch GS","year":"1995","journal-title":"Am J Hum Genet"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320380409"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90283-5"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1089\/10906570050501524"},{"key":"e_1_2_1_18_1","first-page":"3","volume-title":"Fragile X syndrome. Diagnosis, treatment and research","author":"Hagerman RJ","year":"1996"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1675488"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.25.6.407"},{"issue":"4","key":"e_1_2_1_21_1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3310\/hta1040","article-title":"Screening for Fragile X syndrome","volume":"1","author":"Murray J","year":"1997","journal-title":"Health Technol Assess"},{"key":"e_1_2_1_22_1","unstructured":"Office for National Statistics.1995.1995 Birth Statistics. Series FM1 No. 24. (England and Wales). xii."},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0223(200008)20:8<611::AID-PD881>3.0.CO;2-M"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1195-331"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.28.12.830"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112123252401"},{"key":"e_1_2_1_27_1","first-page":"225","article-title":"A multicenter study on genotype\u2010phenotype correlations in Fragile X syndrome, using direct diagnosis with probe StB128: the first 2253 cases","volume":"55","author":"Rousseau F","year":"1994","journal-title":"Am J Hum Genet"},{"key":"e_1_2_1_28_1","first-page":"1006","article-title":"Prevalence of carriers of premutation\u2010size alleles of the FMR1 gene\u2013and implications for the population genetics of the Fragile X syndrome","volume":"57","author":"Rousseau F","year":"1995","journal-title":"Am J Hum Genet"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200285"},{"key":"e_1_2_1_30_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/096914139600300114","article-title":"Screening brief: Cystic fibrosis","volume":"3","author":"Screening brief","year":"1996","journal-title":"J Med Screen"},{"key":"e_1_2_1_31_1","first-page":"165","volume-title":"Fragile X Syndrome. Diagnosis, Treatment and Research","author":"Sherman S","year":"1996"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19960809)64:2<256::AID-AJMG4>3.0.CO;2-S"},{"key":"e_1_2_1_33_1","first-page":"1217","article-title":"Analysis of a CGG sequence at the FMR\u20101 locus in Fragile X families and in the general population","volume":"53","author":"Snow K","year":"1993","journal-title":"Am J Hum Genet"},{"key":"e_1_2_1_34_1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.1994.03510310037035","article-title":"Molecular predictors of cognitive involvement in female carriers of Fragile X syndrome","volume":"271","author":"Taylor AK","year":"1994","journal-title":"JAMA"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1086\/321974"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G"},{"key":"e_1_2_1_37_1","first-page":"195","volume-title":"Turnbulls Obstetrics","author":"Wald NJ","year":"1995"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004390100519"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)65388-3"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.34.3.250"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.252.5009.1179"}],"container-title":["Prenatal Diagnosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpd.586","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pd.586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T13:56:44Z","timestamp":1700229404000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1002\/pd.586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,21]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["10.1002\/pd.586"],"URL":"https:\/\/doi.org\/10.1002\/pd.586","archive":["Portico"],"relation":{},"ISSN":["0197-3851","1097-0223"],"issn-type":[{"value":"0197-3851","type":"print"},{"value":"1097-0223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,21]]}}}